IRADIMED CORPIRMDEarnings & Financial Report
Nasdaq
NextSep 3, 2026
IRMD Q3 2025 Key Financial Metrics
Revenue
$21.2M
Gross Profit
$16.5M
Operating Profit
$6.8M
Net Profit
$5.6M
Gross Margin
77.8%
Operating Margin
32.2%
Net Margin
26.3%
YoY Growth
15.7%
EPS
$0.43
Financial Flow
IRADIMED CORP Q3 2025 Financial Summary
IRADIMED CORP reported revenue of $21.2M for Q3 2025, with a net profit of $5.6M (26.3% margin). Cost of goods sold was $4.7M, operating expenses totaled $9.7M.
Key Financial Metrics
| Total Revenue | $21.2M |
|---|---|
| Net Profit | $5.6M |
| Gross Margin | 77.8% |
| Operating Margin | 32.2% |
| Report Period | Q3 2025 |
IRADIMED CORP Annual Revenue by Year
IRADIMED CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $73.2M).
| Year | Annual Revenue |
|---|---|
| 2024 | $73.2M |
| 2023 | $65.6M |
| 2022 | $53.3M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5M | $17.6M | $17.9M | $18.3M | $19.4M | $19.5M | $20.4M | $21.2M |
| YoY Growth | 17.4% | 13.7% | 11.1% | 11.0% | 11.1% | 10.9% | 13.8% | 15.7% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $92.2M | $88.0M | $89.9M | $94.2M | $98.3M | $101.7M | $106.4M | $114.7M |
| Liabilities | $20.7M | $11.9M | $10.3M | $10.8M | $11.5M | $11.7M | $12.1M | $16.4M |
| Equity | $71.4M | $76.1M | $79.7M | $83.4M | $86.8M | $90.1M | $94.3M | $98.4M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.9M | $3.9M | $6.6M | $9.1M | $6.0M | $4.3M | $7.7M | $7.0M |